Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278947
Max Phase: Preclinical
Molecular Formula: C80H79BN12O15
Molecular Weight: 1459.39
Associated Items:
ID: ALA5278947
Max Phase: Preclinical
Molecular Formula: C80H79BN12O15
Molecular Weight: 1459.39
Associated Items:
Canonical SMILES: CCN(CC)c1ccc2c(c1)Oc1cc(OCc3ccc(B4OC(C)(C)C(C)(C)O4)cc3)c(COC(=O)OC3(CC)C(=O)OCc4c3cc3n(c4=O)Cc4cc5ccccc5nc4-3)cc1C21c2ccccc2CN1CCNC(=O)CCC(NC(=O)c1ccc(NCc2cnc3[nH]c(N)nc(=O)c3n2)cc1)C(=O)O
Standard InChI: InChI=1S/C80H79BN12O15/c1-8-79(58-36-62-67-49(33-47-15-12-14-18-60(47)87-67)41-93(62)72(97)55(58)44-103-74(79)100)106-76(101)104-43-50-34-59-65(37-63(50)102-42-45-19-23-51(24-20-45)81-107-77(4,5)78(6,7)108-81)105-64-35-54(91(9-2)10-3)27-28-57(64)80(59)56-17-13-11-16-48(56)40-92(80)32-31-83-66(94)30-29-61(73(98)99)88-70(95)46-21-25-52(26-22-46)84-38-53-39-85-69-68(86-53)71(96)90-75(82)89-69/h11-28,33-37,39,61,84H,8-10,29-32,38,40-44H2,1-7H3,(H,83,94)(H,88,95)(H,98,99)(H3,82,85,89,90,96)
Standard InChI Key: STZFLYCYKBHCSD-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1459.39 | Molecular Weight (Monoisotopic): 1458.5881 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wang P, Gong Q, Hu J, Li X, Zhang X.. (2021) Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases., 64 (1.0): [PMID:33356214] [10.1021/acs.jmedchem.0c01704] |
Source(1):